Advertisement
U.S. markets close in 1 hour 50 minutes
Advertisement

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
64.31+1.01 (+1.59%)
As of 02:10PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close63.30
Open64.14
Bid64.31 x 800
Ask64.32 x 800
Day's Range63.71 - 64.33
52 Week Range61.73 - 76.56
Volume6,302,960
Avg. Volume5,299,339
Market Cap199.335B
Beta (5Y Monthly)0.19
PE Ratio (TTM)34.02
EPS (TTM)1.89
Earnings DateN/A
Forward Dividend & Yield1.45 (2.29%)
Ex-Dividend DateAug 10, 2023
1y Target Est82.69
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
38% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for AZN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Astrazeneca PLC
    Analyst Report: AstraZeneca PLCAstraZeneca is a British-Swedish company with its main headquarters in the U.K. and regional headquarters in Sweden and the U.S. It focuses on treatments for respiratory, autoimmune, and metabolic conditions, as well as on cardiology, neurology, and oncology drugs.
    Rating
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
  • Business Wire

    AstraZeneca advances scientific leadership in hematology at ASH 2023

    WILMINGTON, Del., November 29, 2023--AstraZeneca will present new clinical and real-world data in multiple hematological conditions at the 65th American Society of Hematology (ASH) Annual Meeting andExposition, December 9 to 12, 2023 in San Diego, CA.

  • Insider Monkey

    15 Hardest Countries to Get Citizenship in Europe

    In this article, we will explore the 15 hardest countries to get citizenship in Europe. You can skip our comprehensive analysis and proceed directly to the 5 Hardest Countries to Get Citizenship in Europe. Obtaining citizenship in European countries often entails strict criteria and requirements. Eligibility typically includes a minimum residency period, clean criminal record, […]

  • Reuters

    UPDATE 2-White House urges RSV immunization makers to meet demand

    Senior Biden administration officials met with the makers of RSV immunizations for children this week to underscore the need for manufacturers such as Sanofi and AstraZeneca to urgently meet demand as winter approaches, the White House said on Tuesday. At a meeting at the White House on Monday, officials and manufacturers also agreed to plan now to meet next year's demand for the immunizations targeting respiratory syncytial virus, which generally causes mild, cold-like symptoms but can develop into severe illness in infants and older adults.